Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cardlytics, Inc.CDLX · Entity 7603 | Chief Legal & Privacy Officer | June 09, 2022 | July 20, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cardlytics, Inc.
Report date June 09, 2022 · Filed July 20, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,130 |
Ending reported balance
After 2022-07-20 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-06-09 · Exercise / conversion · Acquired 7,813 · Balance 53,130 F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered. Row 2 · 2022-07-20 · Sale · Disposed 1,000 · Balance 52,130 F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021. |
| Performance Stock UnitSEC Table II · derivative / convertible security | Direct | 7,812 |
Reported balance
After 2022-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-09 · Exercise / conversion · Disposed 7,813 · Balance 7,812 F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 8, 2021.
F3: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F4: On December 9, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum growth rate in adjusted contribution was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted contribution growth target ("adjusted contribution growth tranche"). Fifty percent (50%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU vested 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the adjusted contribution growth tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 17, 2020 Filed Jan 18, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 919 | $84.88 | $78,004.72 |
DisclosureSEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,893 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $84.86 to $84.99, inclusive. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 450 | $84.13 | $37,858.50 |
DisclosureSEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,812 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $83.86 to $84.21, inclusive. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,409 | $83.06 | $449,271.54 |
DisclosureSEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,262 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $82.83 to $83.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| January 17, 2020 Filed Jan 18, 2020 00:34 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 778 | $20.00 | $15,560.00 |
DisclosureSEC source: 0001666071-20-000011 · wf-form4_157930764628835.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2019. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,893 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GiftCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,093 F1 · price: Shares transferred by the Reporting Person as a bona fide gift without consideration. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · derivative · entry 9 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 10,000 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 261 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · derivative · entry 8 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Common Stock · 261 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 777 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · derivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 777 shares Expires 2024-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 11,038 | $58.00 | $640,204.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,293 Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,000 | $30.44 | $304,400.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 261 | $20.00 | $5,220.00 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 21:21 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 777 | $9.08 | $7,055.16 |
DisclosureSEC source: 0001666071-19-000183 · wf-form4_157670410064066.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 13:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $30.44 | $0.00 |
DisclosureSEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · derivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 15,000 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 13:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,231 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · derivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 777 Underlying: Common Stock · 25,231 shares Expires 2024-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 13:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 15,000 | $60.00 | $900,000.00 |
DisclosureSEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,293 Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 13:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 15,000 | $30.44 | $456,600.00 |
DisclosureSEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 13:54 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 25,231 | $9.08 | $229,097.48 |
DisclosureSEC source: 0001666071-19-000179 · wf-form4_157555405763818.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 5,426 | $56.22 | $305,049.72 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 7 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,062 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of the performance stock units. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.00 to $56.77, inclusive. Read SEC document |
| November 26, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 10,100 | $55.88 | $564,388.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 6 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,488 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of the performance stock units. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.73 to $55.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 13 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Sock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F9 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019, twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification. F9 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the stock price target ("stock price tranche"). Fifty percent (50%) of the shares subject to the stock price tranche of the awarded PSU vested upon the Certification and were delivered on November 25, 2019, twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the stock price tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionPerformance Stock Unit · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 12 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Sock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F8 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. F8 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 11 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Sock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F8 · derivative.exercise_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. F8 · derivative.expiration_date: On November 25, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a minimum cumulative adjusted EBITDA target over a trailing 12-month period of the Issuer's common stock was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the adjusted EBITDA target ("EBITDA tranche"). Fifty percent (50%) of the shares subject to the EBITDA tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the EBITDA tranche of the awarded PSU will vest 12 months after the Certification. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,114 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 10 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,386 Underlying: Common Sock · 9,114 shares Expires 2026-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,671 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 9 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,664 Underlying: Common Sock · 22,671 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,491 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · derivative · entry 8 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,008 Underlying: Common Stock · 1,491 shares Expires 2024-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 5 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 15,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 4 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 33,276 | $56.38 | $1,876,100.88 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,338 Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 31,785 | $20.00 | $635,700.00 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 28, 2019 00:12 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 1,491 | $9.08 | $13,538.28 |
DisclosureSEC source: 0001666071-19-000166 · wf-form4_157489994039629.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2019 Filed Nov 21, 2019 22:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $58.70 | $88,050.00 |
DisclosureSEC source: 0001666071-19-000154 · wf-form4_157437382910540.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,338 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019. F2 · balance_after: Includes 555 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 21, 2019 Filed Oct 21, 2019 20:41 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $38.15 | $57,225.00 |
DisclosureSEC source: 0001666071-19-000130 · wf-form4_157169042183244.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,283 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019. Read SEC document |
| September 30, 2019 Filed Sep 30, 2019 20:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $9.08 | $0.00 |
DisclosureSEC source: 0001666071-19-000124 · wf-form4_156987542066830.xml · derivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,499 Underlying: Common Stock · 10,000 shares Expires 2024-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| September 30, 2019 Filed Sep 30, 2019 20:30 UTC | Cardlytics, Inc. CDLX · Entity 7603 | Exercise / conversionCommon Stock | 10,000 | $9.08 | $90,800.00 |
DisclosureSEC source: 0001666071-19-000124 · wf-form4_156987542066830.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2019 Filed Sep 23, 2019 13:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $35.41 | $53,115.00 |
DisclosureSEC source: 0001666071-19-000117 · wf-form4_156924384913468.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,783 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019. Read SEC document |
| August 26, 2019 Filed Aug 28, 2019 21:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | GrantPerformance Stock Unit · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001666071-19-000105 · wf-form4_156702622063543.xml · derivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Sock · 31,250 shares Expires not disclosed F1 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the first tranche of the PSU to be awarded, which shares are reflected in Column 5 above. Fifty percent (50%) of the shares subject to the first tranche of the PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 12 months after the Certification. The PSU has not yet settled. F2 · derivative.expiration_date: On August 26, 2019, the Compensation Committee of the Issuer's Board of Directors certified that a target minimum trailing 30-day average closing price of the Issuer's common stock was achieved (the "Certification") resulting in the first tranche of the PSU to be awarded, which shares are reflected in Column 5 above. Fifty percent (50%) of the shares subject to the first tranche of the PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the first tranche of the PSU will vest 12 months after the Certification. The PSU has not yet settled. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 20:03 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $32.57 | $48,855.00 |
DisclosureSEC source: 0001666071-19-000094 · wf-form4_156641778134365.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,283 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 20:52 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $27.46 | $41,190.00 |
DisclosureSEC source: 0001666071-19-000070 · wf-form4_156400150426705.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,783 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $27.41 to $27.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 14:56 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 1,500 | $24.05 | $36,075.00 |
DisclosureSEC source: 0001666071-19-000051 · wf-form4_156112896646829.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,283 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $23.85 to $24.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 944 shares of Common Stock acquired under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 29, 2019 Filed Mar 29, 2019 20:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 820 | $16.52 | $13,546.40 |
DisclosureSEC source: 0001209191-19-021787 · doc4.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,839 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.62, inclusive. Read SEC document |
| March 28, 2019 Filed Mar 29, 2019 20:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 831 | $16.30 | $13,545.30 |
DisclosureSEC source: 0001209191-19-021787 · doc4.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,659 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $16.03 to $16.42, inclusive. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 20:53 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 857 | $15.79 | $13,532.03 |
DisclosureSEC source: 0001209191-19-021787 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,490 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.78 to $15.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 26, 2019 Filed Mar 26, 2019 20:46 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 862 | $15.70 | $13,533.40 |
DisclosureSEC source: 0001209191-19-021336 · doc4.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,347 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.67 to $15.83, inclusive. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 20:46 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 887 | $15.26 | $13,535.62 |
DisclosureSEC source: 0001209191-19-021336 · doc4.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,209 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.12 to $15.40, inclusive. Read SEC document |
| March 22, 2019 Filed Mar 26, 2019 20:46 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 846 | $16.00 | $13,536.00 |
DisclosureSEC source: 0001209191-19-021336 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,096 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.77 to $16.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 21:17 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 851 | $15.91 | $13,539.41 |
DisclosureSEC source: 0001209191-19-020806 · doc4.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,942 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.89 to $16.156, inclusive. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 21:17 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 874 | $15.49 | $13,538.26 |
DisclosureSEC source: 0001209191-19-020806 · doc4.xml · nonDerivative · entry 2 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,793 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F3 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.48 to $15.63, inclusive. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 21:17 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 866 | $15.63 | $13,535.58 |
DisclosureSEC source: 0001209191-19-020806 · doc4.xml · nonDerivative · entry 1 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,667 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F2 · price: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.63 to $15.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 18, 2019 Filed Mar 18, 2019 21:04 UTC | Cardlytics, Inc. CDLX · Entity 7603 | SaleCommon Stock | 871 | $15.54 | $13,535.34 |
DisclosureSEC source: 0001209191-19-020036 · doc4.xml · nonDerivative · entry 3 SOMERS KIRK · CIK 0001204015 · Chief Legal & Privacy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,533 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.54 to $15.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.